Discovery of CT365, a highly potent inhibitor of PI3K and mTOR, for cancer treatment

被引：0
|
作者：
Xi, Ning [1 ]
Wu, Yanjun [2 ]
Wang, Tingjin [2 ]
Wang, Heng [2 ]
Li, Zhiyong [2 ]
Meng, Qingwei [2 ]
Li, Jing [2 ]
Wang, Zhaohe [2 ]
Zhang, Yingjun [2 ]
机构：
[1] Calitor Sci LLC, Newbury Pk, CA USA
[2] Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2659
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Discovery of the potent PI3K/mTOR dual inhibitor PF-04979064
    Cheng, Hengmiao
    Bagrodia, Shubha
    Bailey, Simon
    Baxi, Sangita M.
    Goulet, Lance
    Guo, Lisa
    Hoffman, Jacqui
    Johnson, Ted O.
    Johnson, Ted W.
    Li, Chunze
    Li, John
    Liu, Kevin
    Liu, Zhengyu
    Marx, Matthew A.
    Paderes, Gigi
    Sun, Shaoxian
    Walls, Marlena
    Wells, Peter A.
    Yang, Anle
    Yin, Min-Jean
    Zhu, Jingjiang
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [2] Synthesis of PF-04691502, a highly potent PI3K/mTOR dual inhibitor
    Hoffman, Jacqui
    Bailey, Simon
    Cheng, Hengmiao
    Kania, Robert
    Jai, Lei
    Nambu, Mitch
    Ninkovich, Sacha
    Pairish, Mason
    Srirangam, Jay
    Wang, Xiaolong
    Le, Phuong
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [3] Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design
    Cheng, Hengmiao
    Bagrodia, Shubha
    Bailey, Simon
    Edwards, Martin
    Hoffman, Jacqui
    Hu, Qiyue
    Kania, Robert
    Knighton, Daniel R.
    Marx, Matthew A.
    Ninkovic, Sacha
    Sun, Shaoxian
    Zhang, Eric
    [J]. MEDCHEMCOMM, 2010, 1 (02) : 139 - 144
  • [4] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors
    Jia, Hong
    Dai, Guangxiu
    Su, Weiguo
    Xiao, Kun
    Weng, Jianyang
    Zhang, Zhulin
    Wang, Qing
    Yuan, Tianhai
    Shi, Fuying
    Zhang, Zheng
    Chen, Wei
    Sai, Yang
    Wang, Jian
    Li, Xiong
    Cai, Yu
    Yu, Jun
    Ren, Ping
    Venable, Jennifer
    Rao, Tadimeti
    Edwards, James P.
    Bembenek, Scott D.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948
  • [5] VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer
    Hart, Stefan
    Novotny-Diermayr, Veronica
    Goh, Kee Chuan
    Williams, Meredith
    Tan, Yong Cheng
    Ong, Lai Chun
    Cheong, Albert
    Ng, Bee Kheng
    Amalini, Chithra
    Madan, Babita
    Nagaraj, Harish
    Jayaraman, Ramesh
    Pasha, Khalid M.
    Ethirajulu, Kantharaj
    Chng, Wee Joo
    Mustafa, Nurulhuda
    Goh, Boon Cher
    Benes, Cyril
    McDermott, Ultan
    Garnett, Mathew
    Dymock, Brian
    Wood, Jeanette M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (02) : 151 - 161
  • [6] Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
    Knight, Steven D.
    Adams, Nicholas D.
    Burgess, JoeIle L.
    Chaudhari, Amita M.
    Darcy, Michael G.
    Donatelli, Carla A.
    Luengo, Juan I.
    Newlander, Ken A.
    Parrish, Cynthia A.
    Ridgers, Lance H.
    Sarpong, Martha A.
    Schmidt, Stanley J.
    Van Aller, Glenn S.
    Carson, Jeffrey D.
    Diamond, Melody A.
    Elkins, Patricia A.
    Gardiner, Christine M.
    Garver, Eric
    Gilbert, Seth A.
    Gontarek, Richard R.
    Jackson, Jeffrey R.
    Kershner, Kevin L.
    Luo, Lusong
    Raha, Kaushik
    Sherk, Christian S.
    Sung, Chiu-Mei
    Sutton, David
    Tummino, Peter J.
    Wegrzyn, Ronald J.
    Auger, Kurt R.
    Dhanak, Dashyant
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (01): : 39 - 43
  • [7] Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases
    Erra, Montse
    Taltavull, Joan
    Greco, Angelique
    Javier Bernal, Francisco
    Francisco Caturla, Juan
    Gracia, Jordi
    Dominguez, Maria
    Sabate, Mar
    Paris, Stephane
    Soria, Salome
    Hernandez, Begona
    Armengol, Clara
    Cabedo, Judit
    Bravo, Monica
    Calama, Elena
    Miralpeix, Montserrat
    Lehner, Martin D.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (01): : 118 - 123
  • [8] Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design
    Cheng, Hengmiao
    Li, Chunze
    Bailey, Simon
    Baxi, Sangita M.
    Goulet, Lance
    Guo, Lisa
    Hoffman, Jacqui
    Jiang, Ying
    Johnson, Theodore Otto
    Johnson, Ted W.
    Knighton, Daniel R.
    Li, John
    Liu, Kevin K. -C.
    Liu, Zhengyu
    Marx, Matthew A.
    Walls, Marlena
    Wells, Peter A.
    Yin, Min-Jean
    Zhu, Jinjiang
    Zientek, Michael
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (01): : 91 - 97
  • [9] Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor
    Mallon, Robert
    Feldberg, Larry R.
    Lucas, Judy
    Chaudhary, Inder
    Dehnhardt, Christoph
    Delos Santos, Efren
    Chen, Zecheng
    dos Santos, Osvaldo
    Ayral-Kaloustian, Semiramis
    Venkatesan, Aranapakam
    Hollander, Irwin
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (10) : 3193 - 3203
  • [10] Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer
    Wu, Zhengyang
    Bai, Ying
    Jin, Jiaming
    Jiang, Teng
    Shen, Hui
    Ju, Qiurong
    Zhu, Qihua
    Xu, Yungen
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 217
12345